Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms
Masao Takata(Harvard University), Kenneth D. Bloch(Harvard University), Galina Filippov(Harvard University), Heling Liu(Harvard University), Fumito Ichinose(Harvard University), Stefan Janssens(Maastricht University), Donald B. Bloch(Harvard University)
American Journal of Physiology-Lung Cellular and Molecular Physiology
February 1, 2001
Cited by 60
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Inhaled Nitric Oxide
|Circulation|2004|533